
Anthem Biosciences Ltd Holds 20th AGM on July 22, 2026
Anthem Biosciences Ltd announced its 20th Annual General Meeting (AGM) will be held on Wednesday, July 22, 2026, at 3:30 PM IST via Video Conferencing/Other Audio-Visual Means. The company has enclosed its Annual Report for FY 2025-26 in compliance with SEBI Listing Regulations. Shareholders without registered email addresses will receive a separate communication with a web link to access the report. The report is also available on the company's website. The Annual Report highlights the company's strategic pillars of People, Performance, and Progress, emphasizing its role as an innovation-focused CRDMO. Key financial highlights for FY 2025-26 include Revenue from Operations of ₹21,243 Mn, EBITDA of ₹9,896 Mn, PAT of ₹13,743 Mn, and Net Cash of ₹5,918 Mn.
Key Highlights
- AGM scheduled for July 22, 2026, via VC/OAVM.
- Annual Report for FY 2025-26 has been published.
- Revenue from Operations: ₹21,243 Mn.
- PAT: ₹13,743 Mn.
- Company is an innovation-focused CRDMO.
Price Impact
More from ANTHEM